I don’t remember much about the support group meeting that changed everything. I don’t remember the facilitator’s name, the other people’s faces, how long we sat there, or what anyone actually said. What I remember is the moment, somewhere in the middle of someone else’s story, when I looked around…
Discussion
Regulators in the European Union are recommendeding that tolebrutinib be approved as a treatment for people with secondary progressive multiple sclerosis (SPMS) who have not experienced a relapse in the last two years. That new positive opinion was issued by the European Medicines Agency’s Committee for Medicinal Products…
Discussion
Ocrevus (ocrelizumab) delayed disability progression and worsening hand function among a large group of people with primary progressive multiple sclerosis (PPMS), including those who were older and had more advanced disease. The data, which come from the Phase 3 ORATORIO-HAND trial (NCT04035005), were presented by Jiwon Oh,…
Discussion
When I began this column about living with multiple sclerosis (MS) nearly four years ago, I worried about sharing good things in my life and about comparing my situation with that of others. It made me feel guilty. After writing about it, though, the feedback I received from…
Discussion
If I sit for over three minutes, it takes almost that long to regain movement in my legs when I stand. Even then, my limbs must fight the relentless pressure of immobility. Focused therapies, such as the Portable Neuromodulation Stimulator, have given me back years of lost function.
Get regular updates to your inbox.
